微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 1.21% | 676.19% | -65.82% | 65/139 | 1.16% | 惠泰医疗 | 7.54% | 行业排名> |
| 2025-12-31 | 3.54% | 131.95% | 75.25% | 65/139 | 2.07% | 惠泰医疗 | 27.72% | 行业排名> |
| 2025-09-30 | 2.02% | 151.01% | 271.19% | 86/139 | 0.51% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | -1.18% | 44.08% | -461.9% | 112/139 | 1.91% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | -0.21% | 52.27% | 98.1% | 108/139 | 1.04% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | -11.08% | -259.2% | -179.8% | 122/139 | 3.02% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | -3.96% | -160.55% | -87.68% | 117/139 | 4.75% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | -2.11% | -134.14% | -379.55% | 120/139 | 2.98% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | -0.44% | -114.1% | -106.32% | 112/139 | 1.65% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 6.96% | -49.78% | 6.42% | 59/139 | 4.92% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 6.54% | -45.5% | 5.83% | 47/139 | 5.8% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 6.18% | -20.46% | 98.08% | 31/139 | 3.8% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 3.12% | -11.11% | -77.49% | 39/139 | 2.28% | 安杰思 | 8.56% | 行业排名> |
| 2022-12-31 | 13.86% | -9.35% | 15.5% | 44/139 | 12.93% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 12% | -2.52% | 54.44% | 45/139 | 12.7% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 7.77% | 3.74% | 121.37% | 44/139 | 9.24% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 3.51% | -19.31% | -77.04% | 44/139 | 6.21% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 15.29% | 188.49% | 24.21% | 54/139 | 17.28% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 12.31% | 624.12% | 64.35% | 48/139 | 15.82% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 7.49% | 5450% | 72.18% | 54/139 | 11.46% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 4.35% | 488.39% | -17.92% | 36/139 | 6.18% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 5.3% | 554.32% | 211.76% | 105/139 | 25.47% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 1.7% | 73.47% | 1314.29% | 80/139 | 19.63% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | -0.14% | -125.45% | 87.5% | 104/139 | 15.03% | 博拓生物 | 108.13% | 行业排名> |
| 2020-03-31 | -1.12% | -514.81% | -238.27% | 73/139 | 3.37% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | 0.81% | 2.53% | -17.35% | 105/139 | 14.24% | 健尔康 | 84.09% | 行业排名> |
| 2019-09-30 | 0.98% | -65.37% | 78.18% | 64/139 | 10.37% | 祥生医疗 | 28.56% | 行业排名> |
| 2019-06-30 | 0.55% | -72.77% | 103.7% | 70/139 | 6.65% | 心脉医疗 | 31.04% | 行业排名> |
| 2019-03-31 | 0.27% | -73.79% | -65.82% | 55/139 | 2.68% | 新华医疗 | 13.55% | 行业排名> |
| 2018-12-31 | 0.79% | -88.01% | -72.08% | 98/139 | 12.87% | 安旭生物 | 48.71% | 行业排名> |
| 2018-09-30 | 2.83% | -53.98% | 40.1% | 49/139 | 7.11% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2018-06-30 | 2.02% | -43.1% | 96.12% | 49/139 | 3.2% | *ST明德 | 14.54% | 行业排名> |
| 2018-03-31 | 1.03% | -32.68% | -84.37% | 41/139 | 2.61% | 迈瑞医疗 | 11% | 行业排名> |
| 2017-12-31 | 6.59% | -20.7% | 7.15% | 76/139 | 13.76% | 安旭生物 | 59.22% | 行业排名> |
| 2017-09-30 | 6.15% | 0.65% | 73.24% | 32/139 | 9.4% | 大博医疗 | 30.55% | 行业排名> |
| 2017-06-30 | 3.55% | 19.93% | 132.03% | 40/139 | 5.88% | 基蛋生物 | 23.11% | 行业排名> |
| 2017-03-31 | 1.53% | -7.27% | -81.59% | 33/139 | 2.65% | 基蛋生物 | 11.34% | 行业排名> |
| 2016-12-31 | 8.31% | -31.83% | 36.01% | 59/139 | 16.11% | 奥泰生物 | 76.87% | 行业排名> |
| 2016-09-30 | 6.11% | -25.76% | 106.42% | 25/139 | 8.66% | 安图生物 | 28% | 行业排名> |
| 2016-06-30 | 2.96% | -44.98% | 79.39% | 40/139 | 6.24% | *ST明德 | 23.29% | 行业排名> |
| 2016-03-31 | 1.65% | -38.66% | -86.46% | 22/139 | 2.17% | 健帆生物 | 7.75% | 行业排名> |